<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">ACS Biomater Sci Eng</journal-id><journal-id journal-id-type="iso-abbrev">ACS Biomater Sci Eng</journal-id><journal-id journal-id-type="publisher-id">ab</journal-id><journal-id journal-id-type="coden">abseba</journal-id><journal-title-group><journal-title>ACS Biomaterials Science &#x00026; Engineering</journal-title></journal-title-group><issn pub-type="epub">2373-9878</issn><publisher><publisher-name>American
Chemical Society</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26462294</article-id><article-id pub-id-type="pmc">4593359</article-id><article-id pub-id-type="doi">10.1021/acsbiomaterials.5b00032</article-id><article-categories><subj-group><subject>Article</subject></subj-group></article-categories><title-group><article-title><italic>S</italic>-Nitroso-<italic>N</italic>-acetylpenicillamine (SNAP) Impregnated Silicone Foley Catheters:
A Potential Biomaterial/Device To Prevent Catheter-Associated Urinary
Tract Infections</article-title></title-group><contrib-group><contrib contrib-type="author" id="ath1"><name><surname>Colletta</surname><given-names>Alessandro</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath2"><name><surname>Wu</surname><given-names>Jianfeng</given-names></name><xref rid="aff1" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author" id="ath3"><name><surname>Wo</surname><given-names>Yaqi</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath4"><name><surname>Kappler</surname><given-names>Michael</given-names></name><xref rid="aff3" ref-type="aff">&#x000a7;</xref></contrib><contrib contrib-type="author" id="ath5"><name><surname>Chen</surname><given-names>Hao</given-names></name><xref rid="aff3" ref-type="aff">&#x000a7;</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath6"><name><surname>Xi</surname><given-names>Chuanwu</given-names></name><xref rid="cor1" ref-type="other">*</xref><xref rid="aff1" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath7"><name><surname>Meyerhoff</surname><given-names>Mark E.</given-names></name><xref rid="cor2" ref-type="other">*</xref><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><aff id="aff1"><sup>&#x02020;</sup>Department
of Chemistry and <sup>&#x02021;</sup>Department of Environmental Health Sciences, <institution>University of Michigan</institution>, Ann Arbor, Michigan 48109, <country>United States</country></aff><aff id="aff3"><label>&#x000a7;</label><institution>Biocrede
Inc.</institution>, Plymouth, Michigan 48170, <country>United
States</country></aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>E-mail: <email>cxi@umich.edu</email>.</corresp><corresp id="cor2"><label>*</label>E-mail: <email>mmeryho@umich.edu</email>.</corresp></author-notes><pub-date pub-type="pmc-release"><day>27</day><month>04</month><year>2016</year></pub-date><pub-date pub-type="epub"><day>27</day><month>04</month><year>2015</year></pub-date><pub-date pub-type="ppub"><day>08</day><month>06</month><year>2015</year></pub-date><volume>1</volume><issue>6</issue><fpage>416</fpage><lpage>424</lpage><history><date date-type="received"><day>21</day><month>01</month><year>2015</year></date><date date-type="accepted"><day>27</day><month>04</month><year>2015</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2015 American
Chemical Society</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>American
Chemical Society</copyright-holder><license><license-p>This is an open access article published under an ACS AuthorChoice <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/page/policy/authorchoice_termsofuse.html">License</ext-link>, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.</license-p></license></permissions><abstract><p content-type="toc-graphic"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ab-2015-00032j_0007" id="ab-tgr1"/></p><p>Urinary Foley catheters are utilized
for management of hospitalized
patients and are associated with high rates of urinary tract infections
(UTIs). Nitric oxide (NO) potently inhibits microbial biofilm formation,
which is the primary cause of catheter associated UTIs (CAUTIs). Herein,
commercial silicone Foley catheters are impregnated via a solvent
swelling method with <italic>S</italic>-nitroso-<italic>N</italic>-acetyl-D-penicillamine (SNAP), a synthetic NO donor that exhibits
long-term NO release and stability when incorporated into low water-uptake
polymers. The proposed catheters generate NO surface-fluxes &#x0003e;0.7
&#x000d7;
10<sup>&#x02013;10</sup> mol min<sup>&#x02013;1</sup> cm<sup>&#x02013;2</sup> for over one month under physiological conditions, with minimal
SNAP leaching. These biomedical devices are demonstrated to significantly
decrease formation of biofilm on the surface of the catheter tubings
over 3, 7, and 14 day periods by microbial species (<italic>Staphylococcus
epidermidis</italic> and <italic>Proteus mirabilis</italic>) commonly
causing CAUTIs. Toxicity assessment demonstrates that the SNAP-impregnated
catheters are fully biocompatible, as extracts of the catheter tubings
score 0 on a 3-point grading scale using an accepted mouse fibroblast
cell-line toxicity model. Consequently, SNAP-impregnated silicone
Foley catheters can likely provide an efficient strategy to greatly
reduce the occurrence of nosocomial CAUTIs.</p></abstract><kwd-group><kwd> nitric oxide</kwd><kwd>SNAP-impregnated Foley catheters</kwd><kwd>long-term NO release</kwd><kwd>antibiofilm</kwd><kwd>biocompatibility</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>document-id-old-9</meta-name><meta-value>ab5b00032</meta-value></custom-meta><custom-meta><meta-name>document-id-new-14</meta-name><meta-value>ab-2015-00032j</meta-value></custom-meta><custom-meta><meta-name>ccc-price</meta-name><meta-value/></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec1"><title>Introduction</title><p>The insertion of biomedical
devices into the body, such as intravascular
and urinary catheters, represents an indispensable component of modern
medical care, especially for hospitalized patients. Nevertheless,
the use of these medical devices is associated with a substantial
risk of bacterial infections, with catheter-associated urinary tract
infections (CAUTIs) and catheter-related bloodstream infections (CRBSIs)
representing significant medical problems.<sup><xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref2">2</xref></sup> Specifically,
Foley catheters, the most widely utilized indwelling urinary catheters,
play a critical role in the relief of urinary retention, alleviation
of urinary incontinence, and patient management during and after surgical
procedures. Yet, because external bacteria can easily access the urinary
tract, CAUTIs can result in 0.5&#x02013;0.7 million nosocomial infections
annually and account for 40% of hospital-acquired infections in the
United States, representing the most common source of infection in
clinical settings.<sup><xref ref-type="bibr" rid="ref3">3</xref>&#x02212;<xref ref-type="bibr" rid="ref5">5</xref></sup> Because of the high incidence and potential clinical
relevance of these infections, the cost of medical intervention for
CAUTIs is quite significant, with $450 M spent annually in the United
States alone.<sup><xref ref-type="bibr" rid="ref6">6</xref></sup></p><p>It is documented that
microbial biofilms play a significant role
in the pathogenesis of CAUTIs.<sup><xref ref-type="bibr" rid="ref7">7</xref></sup> After the
initial colonization of the abiotic surfaces, uropathogens form hydrated
matrices of extracellular polymeric substances, dubbed as biofilms.
These structures allow for the persistence of bacteria in the urinary
tract by facilitating adhesion to the catheter&#x02019;s surface and
the patient&#x02019;s epithelium, thus protecting the uropathogens
from antibiotics and the host immune system.<sup><xref ref-type="bibr" rid="ref8">8</xref>,<xref ref-type="bibr" rid="ref9">9</xref></sup> Bacteria
within biofilms can also detach and disseminate from the initial site
of colonization to the upper urinary tract, thus being a potential
cause of pyelonephritis.<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> Furthermore,
uropathogenic bacteria can induce precipitation of calcium and magnesium
phosphates, and form urinary stones (staghorn calculi),<sup><xref ref-type="bibr" rid="ref11">11</xref>,<xref ref-type="bibr" rid="ref12">12</xref></sup> which may obstruct urine flow through the catheter and lead to serious
complications. Because 5 million patients each year receive urinary
catheters in the U.S.,<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> and CAUTIs account
for 80% of the total UTIs annually,<sup><xref ref-type="bibr" rid="ref13">13</xref></sup> many
infection control measures have been pursued. Though silver hydrogel
coatings<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> or impregnation of urinary catheters
with antiseptic chemicals reduce the severity of bacteriuria, no methods
have yet been developed that effectively prevent biofilm-induced infections
associated with the use of Foley catheters.<sup><xref ref-type="bibr" rid="ref15">15</xref>,<xref ref-type="bibr" rid="ref16">16</xref></sup></p><p>Nitric oxide (NO), a gas molecule endogenously produced by
various
NO synthase (NOS) enzymes, plays a critical physiological role in
innate immunity by inhibiting proliferation of bacteria, fungi, and
viruses.<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> For these reasons, polymeric
materials that mimic endogenous NO release provide a potential solution
against medical device-associated infections, and it has already been
demonstrated that NO release can effectively prevent bacterial adhesion<sup><xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref19">19</xref></sup> and reduce biofilm development<sup><xref ref-type="bibr" rid="ref20">20</xref>&#x02212;<xref ref-type="bibr" rid="ref22">22</xref></sup> on abiotic surfaces.
Because gaseous NO is short-lived and highly reactive under physiological
conditions, a vast array of NO donor molecules capable of efficiently
storing and delivering NO locally have been studied for potential
biomedical applications. Such molecules include <italic>N</italic>-diazeniumdiolates, <italic>S</italic>-nitrosothiols (RSNOs), nitrates,
and metal-nitrosyl complexes, etc. Lipophilic diazeniumdiolates doped
into polymer films,<sup><xref ref-type="bibr" rid="ref21">21</xref></sup> RSNO-modified xerogels
(where RSNOs are covalently bound to the matrix)<sup><xref ref-type="bibr" rid="ref19">19</xref></sup> and endogenous RSNO catalyst-based coatings<sup><xref ref-type="bibr" rid="ref18">18</xref></sup> all exhibit antimicrobial properties and reduced
bacterial adhesion. Nitric oxide generation via electrochemical reduction
of nitrite<sup><xref ref-type="bibr" rid="ref22">22</xref>,<xref ref-type="bibr" rid="ref23">23</xref></sup> or via reduction of sodium nitroprusside
(SNP)<sup><xref ref-type="bibr" rid="ref20">20</xref>,<xref ref-type="bibr" rid="ref24">24</xref></sup> has also been shown to reduce bacterial
cell viability within biofilm communities. Nevertheless, each of these
NO-release strategies has some inherent drawbacks, in terms of storage
stability, costly synthesis, or less than desirable NO release lifetimes.</p><p>We have recently discovered that silicone rubber and other low
water uptake biomedical polymers (e.g., CarboSil, a thermoplastic
urethane copolymer with a mixed soft segment of poly(dimethylsiloxane)
and hydroxyl-terminated polycarbonate with a hard segment of an aromatic
diisocyanate, MDI (from DSM Biomedical Inc.), and E2As, a copolymer
with a mixed soft segment of poly(dimethylsiloxane) and poly(hexamethylene
oxide) with a methylene diphenyl isocyanate (MDI) hard segment (obtained
from AorTech International, plc)) doped with <italic>S</italic>-nitroso-<italic>N</italic>-acetylpenicillamine (SNAP), a synthetic RSNO, exhibit
remarkable NO release capability and storage stability.<sup><xref ref-type="bibr" rid="ref25">25</xref></sup> However, preparing Foley catheters with SNAP
present during the catheter extrusion process is not possible because
of the instability of SNAP molecule at the elevated temperatures required
for conventional catheter extrusion. To overcome this problem, we
herein describe a simple solvent swelling/impregnation method to incorporate
SNAP into FDA-approved silicone Foley catheter tubing. It has already
been demonstrated that several organic solvents can swell silicone
rubber;<sup><xref ref-type="bibr" rid="ref26">26</xref></sup> thus, in this work, tetrahydrofuran
(THF) is utilized to dissolve SNAP and also swell the silicone catheters
to successfully impregnate them with SNAP. This technique, unlike
the extrusion of polymers under high temperature control,<sup><xref ref-type="bibr" rid="ref27">27</xref></sup> is conducted at room temperature and this reduces
the decomposition of SNAP, the NO donor species. We also demonstrate
that SNAP-impregnated silicone Foley catheter tubing steadily releases
NO for one month at physiological and antimicrobial levels. The resulting
SNAP-impregnated silicone catheter tubing are further shown to significantly
decrease microbial biofilm formation after 14 d exposure to flowing
media inoculated with <italic>Staphylococcus epidermidis</italic> (<italic>S. epidermidis</italic>) or <italic>Proteus mirabilis</italic> (<italic>P. mirabilis</italic>), two bacterial strains that most often induce
CAUTIs.</p></sec><sec id="sec2"><title>Experimental Details</title><sec sec-type="materials" id="sec2.1"><title>Materials</title><p><italic>N</italic>-Acetyl-D-penicillamine
(NAP), sodium chloride, potassium chloride, sodium phosphate dibasic,
potassium phosphate monobasic, L-cysteine, copper chloride, ethylenediaminetetraacetic
acid (EDTA), and tetrahydrofuran (THF) were purchased from Sigma-Aldrich
(St. Louis, MO), and used as received. Methanol (MeOH), hydrochloric
acid (HCl), and sulfuric acid (H<sub>2</sub>SO<sub>4</sub>) were obtained
from Fisher Scientific (Pittsburgh, PA). Luria&#x02013;Bertani (LB)
broth and LB agar were also obtained from Fisher Scientific Inc. Aqueous
solutions were prepared with deionized water using a Milli-Q filter
(18M&#x003a9; cm<sup>&#x02013;1</sup>; Millipore Corp., Billerica, MA).
Phosphate buffered saline (PBS), pH 7.4, containing 10 mM sodium phosphate,
138 mM NaCl, 2.7 mM KCl, 100 &#x003bc;M EDTA was used for all in vitro
experiments.</p><p>Silicone 2-way Foley Balloon Catheters, size 18
Fr (o.d. = 0.59 cm, i.d. = 0.30 cm), were purchased from Fortune Medical
Instrument Corp (New Taipei City, TAIWAN). <italic>S. epidermidis</italic> ATCC 14990 and <italic>P. mirabilis</italic> ATCC 29906 were obtained
from the American Type Culture Collection (ATCC) (Manassas, VA).</p></sec><sec id="sec2.2"><title>Synthesis of SNAP</title><p>SNAP was synthesized using a method
previously described.<sup><xref ref-type="bibr" rid="ref25">25</xref></sup> Briefly, an equimolar
ratio of NAP and sodium nitrite was added to a 3:1 mixture by volume
of methanol and water containing 2 M HCl and 2 M H<sub>2</sub>SO<sub>4</sub>. After 30 min of stirring, the reaction vessel was cooled
in an ice bath to precipitate the green SNAP crystals. After 5 h,
the crystals were collected by filtration, washed with ice-cold water,
and allowed to air-dry for 48 h. The reaction and crystals were shielded
from light at all times.</p></sec><sec id="sec2.3"><title>Preparation of SNAP Impregnated Silicone
Foley Catheters</title><p>SNAP was first dissolved in THF at a concentration
125 mg/mL of solvent,
for 15 min. Commercial FDA approved silicone Foley catheter tubing
was cut either into 1 cm long sections (for NO release measurements,
SNAP % loading and leaching assessments) or into 2 cm long sections
(for biofilm studies). Such segments were completely immersed into
SNAP-containing THF solutions, within glass vials, for 24 h in the
dark. After this swelling/impregnation period, the catheter sections
were dried in dark for 72 h within a fume hood to remove any residual
solvent. Control Foley catheter segments (designated for biofilm experiments)
were swollen in a vial containing only THF for 24 h, followed by a
72 h drying process within the fume hood.</p></sec><sec id="sec2.4"><title>NO Release Measurements</title><p>Nitric oxide release from the
surfaces of 1 cm SNAP-impregnated Foley catheter segments (total surface
area = 3.19 cm<sup>2</sup>) was measured using a Sievers chemiluminescence
Nitric Oxide Analyzer (NOA) 280i (Boulder, CO). Catheter segments
were placed in an amber glass vessel (placed in a water bath at 37
&#x000b0;C) containing 4 mL of PBS (pH 7.4) with 100 &#x003bc;M EDTA. Nitric
oxide released from the catheter segment was continuously purged from
the buffer and swept from the headspace using an N<sub>2</sub> sweep
gas and bubbler into the chemiluminescence detection chamber. When
not being tested with the NOA, the SNAP-impregnated catheters were
incubated in 10 mM PBS (pH 7.4) with 100 &#x003bc;M EDTA at 37 &#x000b0;C,
avoiding exposure to light. All experiments were conducted in triplicate.</p></sec><sec id="sec2.5"><title>SNAP Loading Efficiency Test</title><p>Because the reaction of
2 RSNO &#x02192; RSSR + 2 NO is catalyzed by light in the visible region
of the spectrum,<sup><xref ref-type="bibr" rid="ref28">28</xref></sup> the total loading of
SNAP into the 1 cm catheter segments was determined by the total amount
of NO (in moles) released over time in the presence of a high intensity
white light source (until no additional NO could be detected above
baseline by the NOA). By integrating the signal from the NOA over
time, the total amount of SNAP-impregnated into each catheter segment
can be calculated. Knowing the initial weight of the catheter segment,
the wt % of SNAP within the catheter material can be quantitated.
NO release was measured via the NOA, by immersing the catheter tubing
sample in a clear glass vessel (kept inside a water bath at 37 &#x000b0;C)
containing 50 mM CuCl<sub>2</sub>, and 10 mM <sc>l</sc>-cysteine.
The added L-cysteine catalyzes the reduction of Cu<sup>2+</sup> into
Cu<sup>+</sup>, which then promotes the SNAP decomposition and the
release of NO. A 100W halogen floodlight (GE model 17986) was placed
20 cm away from the sample, and was used to photoinitiate the NO release
from the SNAP-impregnated catheter pieces. All experiments were conducted
in triplicate.</p></sec><sec id="sec2.6"><title>SNAP Leaching from Surface of SNAP Impregnated
Foley Catheters</title><p>One-centimeter-long catheter segments were
completely immersed
into 1 mL of 10 mM PBS (with 100 &#x003bc;M EDTA) inside individual
amber glass vials and stored at 37 &#x000b0;C for the entire duration
of the experiment. At various time points, each of the soaking solutions,
in which catheter segments had been stored, were tested by UV&#x02013;Vis
to detect the SNAP characteristic absorbance band. By using the Beer&#x02013;Lambert
law (<italic>A</italic> = &#x003b5;<italic>lc</italic>), the moles of
SNAP leached out at every time point was calculated. Since the weight
percentage of total SNAP loading was determined from total NO release
(see above), the percentage of leached SNAP can be quantitated. All
UV&#x02013;Vis spectra were recorded in the wavelength range of 250&#x02013;650
nm using a UV&#x02013;Vis spectrophotometer (Lambda 35, PerkineElmer,
MA). The presence of the S-NO group of SNAP provides characteristic
absorbance maxima at 340 and 590 nm, corresponding to the &#x003c0;
&#x02192; &#x003c0;* and n<sub>N</sub> &#x02192; &#x003c0;* electronic transitions.<sup><xref ref-type="bibr" rid="ref29">29</xref>,<xref ref-type="bibr" rid="ref30">30</xref></sup> The molar absorption coefficient for SNAP in PBS at 340 nm was determined
to be &#x003b5;<sub>SNAP</sub> = 1075 M<sup>&#x02013;1</sup> cm<sup>&#x02013;1</sup>. PBS was used as the blank and all experiments were conducted in
triplicate.</p></sec><sec id="sec2.7"><title>Biofilm Growth Conditions and Plate Counting</title><p><italic>S. epidermidis</italic> and <italic>P. mirabilis</italic> organisms
were grown onto surface of control and NO release catheters for 3,
7, and 14 days using a CDC bioreactor. The methods used were similar
to those reported previously.<sup><xref ref-type="bibr" rid="ref23">23</xref>,<xref ref-type="bibr" rid="ref31">31</xref></sup> Details of these microbiology
procedures in relation to the studies reported here are provided in
the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acsbiomaterials.5b00032/suppl_file/ab5b00032_si_001.pdf">Supporting Information</ext-link> file.</p></sec><sec id="sec2.8"><title>Biofilm
Imaging</title><p>Control and SNAP-impregnated catheter
segments designated for fluorescent imaging were stained with LIVE/DEAD
BacLight Bacterial Viability kit (L7012, Invitrogen, Carlsbad, CA)
according to its instructions. Fluorescent images were acquired with
an inverted fluorescence microscope (Olympus IX 71, Center Valley,
PA) equipped with Fluorescence Illumination System (X-Cite 120, EXFO)
and filters for SYTO-9 (excitation = 488 nm/emission = 520 nm) and
Propidium Iodide (excitation = 535 nm/emission = 617 nm). Images were
obtained using an oil immersed 60&#x000d7; objective lens. Only the fluorescent
micrographs of control Foley catheters surfaces upon which <italic>P. mirabilis</italic> had been grown for 14 days were taken with
a 10&#x000d7; objective lens because of the high biofilm biomass on these
pieces of tubing (note: the use of the 60&#x000d7; objective lens would
have impeded to obtain a clear focus of the biofilm layer on the catheter
surfaces). All experiments were conducted in triplicate, and different
surface areas of the catheter segments were randomly chosen for imaging.</p></sec><sec id="sec2.9"><title>Statistical Analysis</title><p>Data for all experiments are expressed
as mean &#x000b1; SEM (standard error of the mean). Comparison of means
using student&#x02019;s <italic>t</italic> test was utilized to analyze
whether there was a statistical difference between the data for SNAP-impregnated
vs control silicone Foley catheter materials. Values of <italic>p</italic> &#x0003c; 0.05 were considered statistically significant and graphically
illustrated with a *.</p><fig id="fig1" position="float"><label>Figure 1</label><caption><p>(a) Structure of <italic>S</italic>-nitroso-<italic>N</italic>-acetyl-<sc>d</sc>-penicillamine (SNAP); (b) scheme of <italic>S</italic>-nitrosothiol
(RSNO) decomposition, where RSNO can release nitric oxide (NO) and
yield the disulfide (RSSR) byproduct via light, heat or catalysis
of metal ions (e.g., Cu(I)); (c) solvent swelling/impregnation method
employed to load commercial Foley catheter silicone tubing with SNAP.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ab-2015-00032j_0002" id="gr1" position="float"/></fig></sec></sec><sec sec-type="results" id="sec3"><title>Results</title><sec id="sec3.1"><title>NO Generation
of SNAP-Impregnated Silicone Foley Catheters</title><p>The total SNAP
amount loaded into Foley catheter segments by the
solvent impregnation method was found to be 5.43 &#x000b1; 0.15 wt %
(<italic>n</italic> = 3) using photolysis to emit the entire payload
of NO in a reasonable time frame (see <xref rid="sec2" ref-type="other">Experimental
Section</xref>). Upon placing the dried tubing segments loaded with
SNAP into PBS buffer at 37 &#x000b0;C, SNAP decomposition within the
walls of the tubing commences owing to the combination of both the
presence of moisture and elevated temperature. NO release data clearly
show that the SNAP-impregnated catheter tubing can release NO at a
flux between 1.4 and 0.8 &#x000d7; 10<sup>&#x02013;10</sup> mol min<sup>&#x02013;1</sup> cm<sup>&#x02013;2</sup> for at least 30 d (see Figure <xref rid="fig2" ref-type="fig">2</xref>a) (note: both outer and inner wall surfaces of
the pieces of tubing are utilized to calculate flux levels). As shown
in Figure <xref rid="fig2" ref-type="fig">2</xref>b, the steady-state NO release profile,
at any given time point for testing the silicone tubing, is relatively
stable after ca. 30 min when studying the NO release in the nitrogen-purged
solution phase using the NOA. It should be noted that the catheter
tubing displays an initial burst of NO during the first few hours
of soaking on day 1 (Figure <xref rid="fig2" ref-type="fig">2</xref>a). This is likely
due to the rapid reaction and leaching of SNAP present in the outermost
surface layers of the silicone tubing. In addition, because it is
known that the pH of urine can vary widely (pH 6.5&#x02013;8.0), the
rate of NO release from separate SNAP-impregnated catheter pieces
was examined over this pH range during the initial week of NO release
testing. It was found that when the pH of the soaking/test buffer
is pH 6.5 or pH 8.0 (using PBS buffers at these pH values), the rate
of NO release from the catheters is not statistically different than
observed when soaking and testing in pH 7.4 PBS (see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acsbiomaterials.5b00032/suppl_file/ab5b00032_si_001.pdf">Figure S1</ext-link>).</p><fig id="fig2" position="float"><label>Figure 2</label><caption><p>(a) Release of NO from SNAP-impregnated silicone Foley
catheter
tubings over a 30 d period (<italic>n</italic> = 3); (b) NO release
profile of one SNAP-impregnated catheter segment after 3 d of soaking
in PBS; (c) percentage of total loaded SNAP that leaches from the
surface of the silicone tubing during the first 7 days of soaking
in PBS at 37 &#x000b0;C. Data are the mean &#x000b1; SEM (<italic>n</italic> = 3).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ab-2015-00032j_0003" id="gr2" position="float"/></fig></sec><sec id="sec3.2"><title>SNAP Leaching from the
Catheter Surface</title><p>To ensure that
SNAP leaching from the catheter polymeric surface is primarily limited
to the first day of soaking because of rapid water uptake at the outermost
surface of the silicone rubber, we conducted leaching studies using
UV&#x02013;vis absorbance spectroscopy over the first 7 days of soaking.
At various time points, the UV&#x02013;vis spectra of aliquots of the
PBS soaking solution were assayed for SNAP concentration. Since the
total SNAP amount loaded into these 1 cm long catheter sections had
previously been quantified, it was determined that only 3.51 &#x000b1;
0.04% of the total loaded SNAP leached from the catheter segment on
the first day of soaking (see Figure <xref rid="fig2" ref-type="fig">2</xref>c). Minimal
amounts of SNAP continued to leach from the Foley catheters during
the subsequent days of soaking. Indeed, only 10.92 &#x000b1; 0.05% of
the total SNAP was lost during the first week (see Figure <xref rid="fig2" ref-type="fig">2</xref>c). It should be noted that NAP and/or NAP disulfide
leaching from the catheter surface is not considered a major concern,
because <italic>N</italic>-acetyl-penicillamine has been used clinically
to treat mercury and other heavy metal poisoning for many years.<sup><xref ref-type="bibr" rid="ref32">32</xref></sup></p></sec><sec id="sec3.3"><title>SNAP Impregnated Foley Catheters Antibiofilm
Properties against <italic>S. epidermidis</italic></title><p>The total
viable <italic>S. epidermidis</italic> adhered on the catheter tubing
surface was determined after growing
biofilms for either 3, 7, or 14 days at 37 &#x000b0;C. Plate count data
for 3 day old <italic>S. epidermidis</italic> biofilms show that the
viable bacteria attached on the surface of the SNAP-impregnated catheter
tubing is ca. 50% less than on controls (Figure <xref rid="fig3" ref-type="fig">3</xref>a; <italic>n</italic> = 3, <italic>p</italic> value = 0.014). Plate
count data for 7 day <italic>S. epidermidis</italic> biofilms exhibited
a significant 2.5 log units difference in viable bacteria between
control and NO releasing catheter segments (Figure <xref rid="fig3" ref-type="fig">3</xref>a; <italic>n</italic> = 3, <italic>p</italic> value = 0.015).
Similarly, when <italic>S. epidermidis</italic> biofilms were grown
for 14 days and reached a matured growth stage, the reduction in adhered
viable bacteria on SNAP-impregnated catheters compared to controls
differs by 3.7 logarithmic units (Figure <xref rid="fig3" ref-type="fig">3</xref>a; <italic>n</italic> = 3, <italic>p</italic> value = 0.013). Fluorescence imaging
data of control and SNAP-impregnated catheter segments after 3, 7,
or 14 days of growth were also collected. As shown in Figure <xref rid="fig3" ref-type="fig">3</xref>b, it is observed that although biofilm thickness
and surface coverage increases with incubation time on control catheters,
they remain relatively low over time on the surfaces of the SNAP-impregnated
catheters.</p><fig id="fig3" position="float"><label>Figure 3</label><caption><p><italic>S. epidermidis</italic> biofilms developed on Foley catheters
segments in a CDC biofilm reactor for 3, 7, and 14 days. (a) Plate
count of the number of viable bacteria adhered to the catheter surface;
(b) representative fluorescence images with oil immersion 60&#x000d7;
objective lens of 3, 7, and 14 day <italic>S. epidermidis</italic> biofilms on the surface of the catheter tubing.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ab-2015-00032j_0004" id="gr3" position="float"/></fig></sec><sec id="sec3.4"><title>SNAP Impregnated Foley Catheters Antibiofilm Properties against <italic>P. mirabilis</italic></title><p>Results for 3 day <italic>P. mirabilis</italic> biofilms show a 3 logarithmic units difference in cell viability
between the SNAP-impregnated and control catheter segments (Figure <xref rid="fig4" ref-type="fig">4</xref>a; <italic>n</italic> = 3, <italic>p</italic> value
= 0.02). Cell counts for 7 and 14 day <italic>P. mirabilis</italic> biofilms grown on the surface of SNAP-impregnated catheter tubing
are 5 (Figure <xref rid="fig4" ref-type="fig">4</xref>a, <italic>n</italic> = 3, <italic>p</italic> value = 0.02) and 6 (Figure <xref rid="fig4" ref-type="fig">4</xref>a, <italic>n</italic> = 3, <italic>p</italic> value = 0.007) log units lower
than those for controls, respectively. These findings are further
corroborated by the fluorescent imaging data, which shows that bacterial
surface coverage on the SNAP-impregnated catheter segments is noticeably
less than controls (see Figure <xref rid="fig4" ref-type="fig">4</xref>b). These results
demonstrate that NO releasing SNAP-impregnated Foley catheters could
provide a novel approach to prevent catheter surface encrustation
by crystalline biofilm-forming bacterial species.</p><fig id="fig4" position="float"><label>Figure 4</label><caption><p><italic>P. mirabilis</italic> biofilms developed on Foley catheter
segments in a CDC biofilm reactor for 3, 7, and 14 days. (a) Plate
count of the number of viable bacteria adhered to the catheter surface;
(b) representative fluorescence images with oil immersion 60&#x000d7;
objective lens of 3, 7, and 14 day <italic>P. mirabilis</italic> biofilms
(note: for control catheters at day 14, because of high biofilm biomass,
images were taken with a 10&#x000d7; objective lens).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ab-2015-00032j_0005" id="gr4" position="float"/></fig></sec><sec id="sec3.5"><title><italic>P. mirabilis</italic> Antibiofilm
Study after Presoaking
SNAP Catheters for 24 h</title><p>Chemiluminescence data from the NOA
shows that the impregnated catheters display an initial burst of NO
during the first day of soaking at 37 &#x000b0;C, which is due to the
thermal decomposition and the diffusion of SNAP out of the polymeric
surface of the catheters. The bactericidal efficacies of NO releasing
materials improve with increasing initial NO flux.<sup><xref ref-type="bibr" rid="ref32">32</xref>,<xref ref-type="bibr" rid="ref33">33</xref></sup> To ensure that SNAP-impregnated catheters&#x02019; antibiofilm properties
were not due to the bactericidal effect of an initial high NO flux
(4.5 mol min<sup>&#x02013;1</sup> cm<sup>&#x02013;2</sup>) during the
initial hours of antibacterial studies in the bioreactor, we conducted
additional experiments in which the SNAP catheters were first presoaked
in PBS at 37 &#x000b0;C for 24 h. After this presoaking step, 3 days <italic>P. mirabilis</italic> antibiofilms studies were conducted exactly
as described above. Plate count data of viable bacteria adhered on
the catheter surfaces clearly illustrates that there is more than
3 logarithmic units difference between controls and presoaked SNAP-impregnated
catheters (Figure <xref rid="fig5" ref-type="fig">5</xref>a, <italic>n</italic> =
6, <italic>p</italic> value = 0.010). Fluorescent images also show
that bacterial surface coverage of presoaked SNAP-impregnated catheters
is noticeably less than controls (see Figure <xref rid="fig5" ref-type="fig">5</xref>b).</p><fig id="fig5" position="float"><label>Figure 5</label><caption><p><italic>P. mirabilis</italic> biofilms developed on Foley catheter
segments in a CDC biofilm reactor for 3 days. SNAP-impregnated catheters
presoaked in PBS buffer for 24 h prior to the beginning of biofilm/bioreactor
experiment. (a) Plate count of the number of viable bacteria adhered
to the catheter surface. (b) Representative fluorescence Images with
oil immersion 60&#x000d7; objective lens of catheter surfaces after 3
days of growth of <italic>P. mirabilis</italic> biofilms.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ab-2015-00032j_0006" id="gr5" position="float"/></fig></sec><sec id="sec3.6"><title>SNAP Impregnated Foley Catheters NO Releasing
Properties Post <italic>P. mirabilis</italic> Antibiofilm Experiment</title><p>The NO releasing
profile of three SNAP catheter segments, presoaked in PBS prior to
the beginning of a 3 day <italic>P. mirabilis</italic> biofilm experiment,
were tested via the NOA at the end of the biofilm growth period. As
shown in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acsbiomaterials.5b00032/suppl_file/ab5b00032_si_001.pdf">Figure S2</ext-link>, the SNAP-impregnated
catheter segments can still release NO at a flux &#x0003e;1 &#x000d7; 10<sup>&#x02013;10</sup> mol min<sup>&#x02013;1</sup> cm<sup>&#x02013;2</sup> at the end of the biofilm experiment (96 h post initial soaking
step) (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acsbiomaterials.5b00032/suppl_file/ab5b00032_si_001.pdf">Figure S2</ext-link>, <italic>n</italic> =
3). Further, the NO releasing properties of the same catheter segments
were then also tested on the following day, and the NO flux remained
relatively constant (120 h post initial soaking step) (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acsbiomaterials.5b00032/suppl_file/ab5b00032_si_001.pdf">Figure S2</ext-link>, <italic>n</italic> = 3).</p></sec></sec><sec sec-type="discussion" id="sec4"><title>Discussion</title><p>The long-term NO release data confirms that this impregnation method,
conducted at room temperature, allows for the successful incorporation
of SNAP within the polymer, and that NO release can last for over
1 month at relatively constant flux levels, with minimal leaching
of the total loaded SNAP after the first day of soaking (Figure <xref rid="fig2" ref-type="fig">2</xref>a, c). This illustrates the advantage of using the
simple solvent impregnation approach over extruding the polymer with
the NO donor present, as the latter would degrade the SNAP (loss in
NO) because the elevated temperatures required.<sup><xref ref-type="bibr" rid="ref27">27</xref></sup></p><p>Because stable NO releasing devices can abate bacterial
adhesion
and colonization associated with catheterization, we examined the
antimicrobial properties of the SNAP-impregnated silicone Foley catheter
segments with bacterial strains associated with CAUTIs. Initially, <italic>Staphylococcus epidermidis</italic>, a species responsible for both
intravascular and urinary infections,<sup><xref ref-type="bibr" rid="ref35">35</xref></sup> was studied. As the CDC biofilm reactor represents a standardized
model to replicate in vivo urinary tract conditions,<sup><xref ref-type="bibr" rid="ref31">31</xref></sup> this methodology was utilized to simulate the development
of bacterial biofilms on the surface of urinary Foley catheters. Remarkably,
the viable <italic>S. epidermidis</italic> adhered on the surface
of SNAP catheter tubing after growing biofilms for 7 and 14 days was
reduced by 2.5 and 3.5 log units, respectively, relative to the controls
(see Figure <xref rid="fig3" ref-type="fig">3</xref>a). However, it should be noted
that reduction of bacterial viability for 3 d old <italic>S. epidermidis</italic> biofilms was moderate, only 50% less than on control surfaces. A
plausible reason for this finding may be that the bacteria had not
yet developed into a mature biofilm, but were still in a microcolony
growth stage. Because bacterial counts on the control surfaces were
also low, this fact did not allow a high percentage difference between
the SNAP-doped and control catheters to be observed. Thus, from the
analysis of plate count data (Figure <xref rid="fig3" ref-type="fig">3</xref>a), it
is evident that the SNAP-impregnated catheter segments can progressively
reduce formation of <italic>S. epidermidis</italic> biofilms. This
finding is substantiated by the fluorescence imaging data (Figure <xref rid="fig3" ref-type="fig">3</xref>b).</p><p>Although <italic>S. epidermidis</italic> represents a commensal
inhabitant of healthy mucosal microflora and displays lower pathogenic
potential than <italic>S. aureus</italic>, <italic>P. mirabilis</italic>, and <italic>P. aeruginosa</italic>,<sup><xref ref-type="bibr" rid="ref36">36</xref></sup> its principle virulence factor is the capacity to form high-biomass
biofilms and colonize biomaterials.<sup><xref ref-type="bibr" rid="ref37">37</xref>&#x02212;<xref ref-type="bibr" rid="ref39">39</xref></sup> It has been reported
that biofilm-forming clinical strains of <italic>S. epidermidis</italic>, isolated from urinary tract infections, are significantly more
resistant to a wide array of antibiotic treatments (e.g., ampicillin,
ciprofloxacin, gentamicin, levofloxacin) than nonbiofilm producing
strains.<sup><xref ref-type="bibr" rid="ref40">40</xref>,<xref ref-type="bibr" rid="ref41">41</xref></sup> It has been suggested that the biofilm extracellular
polysaccharide substance (EPS) represents a physical and chemical
barrier to antibiotics,<sup><xref ref-type="bibr" rid="ref42">42</xref></sup> and may thus
retard the penetration rates enough to induce the expression of genes
that mediate antibiotic resistance.<sup><xref ref-type="bibr" rid="ref43">43</xref></sup> Low
susceptibility to antibiotics may also be related to the metabolic
state of bacteria within biofilms.<sup><xref ref-type="bibr" rid="ref44">44</xref></sup> As
the cells located within the biofilm experience nutrient limitation,
this condition can result in a stationary phase-like dormancy, thus
promoting biofilm resistance to antibiotics as compared to planktonic
stage-bacteria.<sup><xref ref-type="bibr" rid="ref45">45</xref>,<xref ref-type="bibr" rid="ref46">46</xref></sup> Hence, the findings that SNAP-impregnated
Foley catheters significantly limit <italic>S. epidermidis</italic> viability may represent a future strategy to prevent nosocomial
urinary infections.</p><p>Because the plate count and fluorescent
imaging data for <italic>S. epidermidis</italic> biofilms exhibit
a significant difference
between SNAP-impregnated and control catheters, the same experiments
were conducted with <italic>P. mirabilis</italic>, the primary bacterium
associated with complicated urinary tract infections.<sup><xref ref-type="bibr" rid="ref47">47</xref>,<xref ref-type="bibr" rid="ref48">48</xref></sup> This urease positive strain is capable of establishing mature crystalline
biofilms,<sup><xref ref-type="bibr" rid="ref11">11</xref>,<xref ref-type="bibr" rid="ref48">48</xref></sup> thus complicating the management of patients
relying on long-term catheterization. Indeed, this bacterium, by catalyzing
the conversion of urea into ammonia, elevates urine pH and causes
calcium/magnesium phosphates to precipitate and become incorporated
into biofilms.<sup><xref ref-type="bibr" rid="ref49">49</xref></sup> As this condition leads
to severe clinical sequelae, prevention strategies are sorely needed.</p><p>We demonstrate that SNAP-doped catheter tubing substantially decreases
bacterial viability at each stage of biofilm maturation (see Figure <xref rid="fig4" ref-type="fig">4</xref>a, b), and that the difference in viable <italic>P. mirabilis</italic> cell counts between SNAP and control catheters
increases with biofilm growth time. This indicates that the SNAP-doped
catheters, by releasing NO, progressively reduce biofilm development.
Further, it should be noted that <italic>P. mirabilis</italic> biofilms
developed to a mature stage after only 3 d of growth, and that average
biofilm thickness progressively increased at later time points. Indeed,
the plate count data of control catheters for the <italic>P. mirabilis</italic> experiments are significantly higher compared to <italic>S. epidermidis</italic> biofilms, which is supported by fluorescent micrographs that show
significantly greater biomass (see Figure <xref rid="fig4" ref-type="fig">4</xref>b). One explanation may be that <italic>P. mirabilis</italic>, by
expressing mannose-resistant/<italic>Proteus</italic>-like (MR/P)
fimbriae and <italic>P. mirabilis</italic> fimbriae (PMF), can rapidly
adhere/colonize onto the abiotic surfaces.<sup><xref ref-type="bibr" rid="ref50">50</xref>,<xref ref-type="bibr" rid="ref51">51</xref></sup></p><p>Our findings with <italic>P. mirabilis</italic> are significant
because, to the best of our knowledge, this is the first report of
a synthetic NO-donor with extremely stable NO release at low/nontoxic
fluxes, that is capable of preventing <italic>P. mirabilis</italic> mature biofilm formation. Earlier, Deupree et al. demonstrated that
a synergistic activity of diazeniumdiolate-modified proline (PROLI/NO)
and sulfadiazine (AgSD) exerts antimicrobial activity against <italic>P. mirabilis</italic> in vitro.<sup><xref ref-type="bibr" rid="ref52">52</xref></sup> Yet,
since in that work, overnight bacterial cultures were utilized in
an acute (2 h) time-kill viability assay, the bactericidal properties
of the chemicals were only investigated on planktonic cells. The antimicrobial
efficacy of antibiotics and antiseptics coated devices has also been
previously evaluated.<sup><xref ref-type="bibr" rid="ref53">53</xref>,<xref ref-type="bibr" rid="ref54">54</xref></sup> Nevertheless, though in vitro
testing of Foley catheters coated with the antiseptic gendine significantly
reduced both Gram-positive and Gram-negative bacterial cell counts,
those biofilms were only cultured for 24 h.<sup><xref ref-type="bibr" rid="ref53">53</xref></sup> Furthermore, although preliminary clinical trials assessing the
antimicrobial properties of urinary catheters impregnated with antibiotics
have been conducted and catheter-associated Gram-positive bacteriuria
was significantly reduced, no protection against Gram-negative bacteria,
the leading cause of CAUTIs, was achieved.<sup><xref ref-type="bibr" rid="ref54">54</xref></sup> Moreover, although initial antibiotic dosages can be effective,
over time, they induce tolerance and resistance.<sup><xref ref-type="bibr" rid="ref55">55</xref>&#x02212;<xref ref-type="bibr" rid="ref57">57</xref></sup> Instead, many
bacteria have not developed efficient strategies to combat the local
bactericidal/biofilm dispersal effect of NO. Indeed, though some bacterial
species (e.g., <italic>P. aeruginosa</italic>) express NO reductase
(Nor) enzymes, that catalyzes NO conversion to N<sub>2</sub>O, biofilm
development by wild-type <italic>P. aeruginosa</italic> can still
be abated by NO donors.<sup><xref ref-type="bibr" rid="ref20">20</xref>,<xref ref-type="bibr" rid="ref24">24</xref></sup> Thus, NO releasing
SNAP-impregnated Foley catheters may provide a useful strategy to
prevent nosocomial CAUTIs by various bacterial strains.</p><p>In addition,
our results are corroborated by the fact that the
antimicrobial properties of our new NO releasing materials are independent
of really high NO flux displayed during the first hours of soaking
at 37 &#x000b0;C. Indeed, even when SNAP catheters are presoaked for
24 h before the start of the biofilm experiment, viable <italic>P.mirabilis</italic> cell counts for NO releasing catheters are significantly lower than
controls (Figure <xref rid="fig5" ref-type="fig">5</xref>a, b). It can thus be concluded
that the release of high NO levels during day 1 was not the major
factor contributing to the potent antibiofilm properties of SNAP-impregnated
catheters observed in the initial experiments.</p><p>It should be
noted that previous studies have demonstrated how
high initial NO fluxes augment the bactericidal efficacy and further
inhibit bacterial adhesion on polymeric material surfaces.<sup><xref ref-type="bibr" rid="ref33">33</xref>,<xref ref-type="bibr" rid="ref34">34</xref></sup> However, because studies investigating nontoxic NO flux thresholds
in urinary tract tissues have yet to be conducted, in this work, we
aimed for SNAP-impregnated catheters to generate NO within ranges
similar to those released by healthy endothelial cells (0.5&#x02013;4.0
mol &#x000d7; 10<sup>&#x02212;10</sup> mol min<sup>&#x02013;1</sup> cm<sup>&#x02013;2</sup>).</p><p>Finally, as shown in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acsbiomaterials.5b00032/suppl_file/ab5b00032_si_001.pdf">Figure S2</ext-link>, we demonstrate
that SNAP-impregnated catheter segments, presoaked in PBS prior to
the beginning of a 3 day <italic>P. mirabilis</italic> biofilm experiment,
can still release NO at a flux &#x0003e;1 &#x000d7; 10<sup>&#x02013;10</sup> mol
min<sup>&#x02013;1</sup> cm<sup>&#x02013;2</sup> at the end of the biofilm
experiment (96 and 120 h post the initial soaking step). These results
provide further evidence that the antibiofilm activity of SNAP-impregnated
catheters is due to the steady long-term NO release properties of
these newly proposed biomedical devices.</p></sec><sec sec-type="conclusions" id="sec5"><title>Conclusions</title><p>In
summary, we have demonstrated that an FDA approved silicone
Foley catheter material can be impregnated with SNAP via a solvent
swelling method and that the resulting catheters can release a relatively
steady NO flux at their surfaces for 30 days. Because no extrusion
process is required for the incorporation of the NO donor/antimicrobial
agent into the catheter walls with little or no chemical degradation
of the SNAP, the catheters should maintain functionality with stable
NO release capability. The SNAP-impregnated catheter tubings were
also shown to exhibit significant antibiofilm properties using two
bacteria strains (<italic>S. epidermidis</italic> and <italic>P. mirabilis</italic>) that are responsible for high rates of nosocomial urinary catheter
associated infections. Furthermore, a preliminary assessment of the
toxicity of SNAP-impregnated catheter tubing was provided by Wuxi
AppTec Inc. (St. Paul, MN) using ISO-based GLP biocompatibility studies.
The catheter tubing received the safest scores possible (0) for in
vitro toxicity testing (0&#x02013;1 = safe, 3&#x02013;4 = toxic) on
L-929 Mouse Fibroblast Cells (extracts were taken from the catheter
pieces stored for 24 h at 37 &#x000b0;C in Eagle&#x02019;s Minimal Essential
Media), as well as for in vivo testing in mice (extracts were taken
from the catheter pieces stored for 72 h at 37 &#x000b0;C in both saline
and sesame oil). Hence, it is likely that SNAP-impregnated Foley urinary
catheters could provide an inexpensive and safe approach to dramatically
reducing the frequency of nosocomial CAUTIs, and studies are now planned
to evaluate this new approach in vivo via long-term animal testing.</p></sec></body><back><notes id="notes-1" notes-type="si"><title>Supporting Information Available</title><p> The Supporting
Information
is available free of charge on the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org">ACS Publications website</ext-link> at DOI: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/abs/10.1021/acsbiomaterials.5b00032">10.1021/acsbiomaterials.5b00032</ext-link>.<list list-type="simple"><list-item><p>Details
on biofilm growth conditions and plate counting
for <italic>S. epidermidis</italic> and <italic>P. mirabilis</italic>; the effect of soaking and test pH values on NO release fluxes from
SNAP-impregnated silicone Foley catheters (Figure S1); and the NO
release properties of SNAP-impregnated Foley catheters post <italic>P. mirabilis</italic> antibiofilm experiments (Figure S2) (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acsbiomaterials.5b00032/suppl_file/ab5b00032_si_001.pdf">PDF</ext-link>)</p></list-item></list></p></notes><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="sifile1"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ab5b00032_si_001.pdf"><caption><p>ab5b00032_si_001.pdf</p></caption></media></supplementary-material></sec><notes id="notes-2" notes-type="conflict-of-interest"><p>The authors
declare the following competing financial interest(s): Mr. Michael
Kappler and Dr. Hao Chen are employees of Biocrede Inc. Dr. Hao Chen
has an equity position in this start-up company. The company received
the STTR grant cited from the NIH. The remaining authors have no equity
position in Biocrede Inc. and work solely for the University of Michigan.
A subaward from Biocrede to the University of Michigan funded most
of the research described in this manuscript.</p></notes><ack><title>Acknowledgments</title><p>We thank the National Institutes of Health for supporting
these studies via grant # NIH-R42-DK100161-02.</p></ack><ref-list><title>References</title><ref id="ref1"><mixed-citation publication-type="journal" id="cit1"><name><surname>Von
Eiff</surname><given-names>C.</given-names></name>; <name><surname>Jansen</surname><given-names>B.</given-names></name>; <name><surname>Kohnen</surname><given-names>W.</given-names></name>; <name><surname>Becker</surname><given-names>K.</given-names></name>
<article-title>Infections associated
with medical devices: pathogenesis, management and prophylaxis</article-title>. <source>Drugs</source>
<year>2005</year>, <volume>65</volume>, <fpage>179</fpage>&#x02013;<lpage>214</lpage><pub-id pub-id-type="doi">10.2165/00003495-200565020-00003</pub-id>.<pub-id pub-id-type="pmid">15631541</pub-id></mixed-citation></ref><ref id="ref2"><mixed-citation publication-type="journal" id="cit2"><name><surname>Umscheid</surname><given-names>C. A.</given-names></name>; <name><surname>Mitchell</surname><given-names>M. D.</given-names></name>; <name><surname>Doshi</surname><given-names>J. A.</given-names></name>; <name><surname>Agarwal</surname><given-names>R.</given-names></name>; <name><surname>Williams</surname><given-names>K.</given-names></name>; <name><surname>Brennan</surname><given-names>P. J.</given-names></name>
<article-title>Estimating the proportion of healthcare-associated
infections that are reasonably preventable and the related mortality
and costs</article-title>. <source>Infect. Control Hosp. Epidemiol.</source>
<year>2011</year>, <volume>32</volume>, <fpage>101</fpage>&#x02013;<lpage>114</lpage><pub-id pub-id-type="doi">10.1086/657912</pub-id>.<pub-id pub-id-type="pmid">21460463</pub-id></mixed-citation></ref><ref id="ref3"><mixed-citation publication-type="journal" id="cit3"><name><surname>Maki</surname><given-names>D. G.</given-names></name>; <name><surname>Tambyah</surname><given-names>P. a.</given-names></name>
<article-title>Engineering out
the risk for infection with urinary
catheters</article-title>. <source>Emerg. Infect. Dis.</source>
<year>2001</year>, <volume>7</volume>, <fpage>342</fpage>&#x02013;<lpage>347</lpage><pub-id pub-id-type="doi">10.3201/eid0702.700342</pub-id>.<pub-id pub-id-type="pmid">11294737</pub-id></mixed-citation></ref><ref id="ref4"><mixed-citation publication-type="journal" id="cit4"><name><surname>Hooton</surname><given-names>T. M.</given-names></name>; <name><surname>Bradley</surname><given-names>S. F.</given-names></name>; <name><surname>Cardenas</surname><given-names>D. D.</given-names></name>; <name><surname>Colgan</surname><given-names>R.</given-names></name>; <name><surname>Geerlings</surname><given-names>S. E.</given-names></name>; <name><surname>Rice</surname><given-names>J. C.</given-names></name>; <name><surname>Saint</surname><given-names>S.</given-names></name>; <name><surname>Schaeffer</surname><given-names>a. J.</given-names></name>; <name><surname>Tambayh</surname><given-names>P. a.</given-names></name>; <name><surname>Tenke</surname><given-names>P.</given-names></name>; et al. <article-title>Diagnosis,
prevention,
and treatment of catheter-associated urinary tract infection in adults:
2009 international clinical practice guidelines from the Infectious
Diseases Society of America</article-title>. <source>Clin. Infect. Dis.</source>
<year>2010</year>, <volume>50</volume>, <fpage>625</fpage>&#x02013;<lpage>663</lpage><pub-id pub-id-type="doi">10.1086/650482</pub-id>.<pub-id pub-id-type="pmid">20175247</pub-id></mixed-citation></ref><ref id="ref5"><mixed-citation publication-type="journal" id="cit5"><name><surname>Oman</surname><given-names>K. S.</given-names></name>; <name><surname>Makic</surname><given-names>M. B. F.</given-names></name>; <name><surname>Fink</surname><given-names>R.</given-names></name>; <name><surname>Schraeder</surname><given-names>N.</given-names></name>; <name><surname>Hulett</surname><given-names>T.</given-names></name>; <name><surname>Keech</surname><given-names>T.</given-names></name>; <name><surname>Wald</surname><given-names>H.</given-names></name>
<article-title>Nurse-directed
interventions
to reduce catheter-associated urinary tract infections</article-title>. <source>Am. J. Infect. Control</source>
<year>2012</year>, <volume>40</volume>, <fpage>548</fpage>&#x02013;<lpage>553</lpage><pub-id pub-id-type="doi">10.1016/j.ajic.2011.07.018</pub-id>.<pub-id pub-id-type="pmid">22047997</pub-id></mixed-citation></ref><ref id="ref6"><mixed-citation publication-type="journal" id="cit6"><name><surname>Tambyah</surname><given-names>P. A.</given-names></name>; <name><surname>Knasinski</surname><given-names>V.</given-names></name>; <name><surname>Maki</surname><given-names>D. G.</given-names></name>
<article-title>The direct costs
of nosocomial catheter-associated
urinary tract infection in the era of managed care</article-title>. <source>Infect. Control Hosp. Epidemiol.</source>
<year>2002</year>, <volume>23</volume>, <fpage>27</fpage>&#x02013;<lpage>31</lpage><pub-id pub-id-type="doi">10.1086/501964</pub-id>.<pub-id pub-id-type="pmid">11868889</pub-id></mixed-citation></ref><ref id="ref7"><mixed-citation publication-type="journal" id="cit7"><name><surname>Donlan</surname><given-names>R. M.</given-names></name>
<article-title>Biofilms
and device-associated infections</article-title>. <source>Emerg. Infect.
Dis.</source>
<year>2001</year>, <volume>7</volume>, <fpage>277</fpage>&#x02013;<lpage>281</lpage><pub-id pub-id-type="doi">10.3201/eid0702.700277</pub-id>.<pub-id pub-id-type="pmid">11294723</pub-id></mixed-citation></ref><ref id="ref8"><mixed-citation publication-type="journal" id="cit8"><name><surname>Mah</surname><given-names>T. F. C.</given-names></name>; <name><surname>O&#x02019;Toole</surname><given-names>G. A.</given-names></name>
<article-title>Mechanisms
of biofilm resistance
to antimicrobial agents</article-title>. <source>Trends Microbiol.</source>
<year>2001</year>, <volume>9</volume>, <fpage>34</fpage>&#x02013;<lpage>39</lpage><pub-id pub-id-type="doi">10.1016/S0966-842X(00)01913-2</pub-id>.<pub-id pub-id-type="pmid">11166241</pub-id></mixed-citation></ref><ref id="ref9"><mixed-citation publication-type="journal" id="cit9"><name><surname>Jacobsen</surname><given-names>S. M.</given-names></name>; <name><surname>Stickler</surname><given-names>D. J.</given-names></name>; <name><surname>Mobley</surname><given-names>H. L. T.</given-names></name>; <name><surname>Shirtliff</surname><given-names>M. E.</given-names></name>
<article-title>Complicated
catheter-associated urinary tract infections due to Escherichia coli
and Proteus mirabilis</article-title>. <source>Clin. Microbiol. Rev.</source>
<year>2008</year>, <volume>21</volume>, <fpage>26</fpage>&#x02013;<lpage>59</lpage><pub-id pub-id-type="doi">10.1128/CMR.00019-07</pub-id>.<pub-id pub-id-type="pmid">18202436</pub-id></mixed-citation></ref><ref id="ref10"><mixed-citation publication-type="journal" id="cit10"><name><surname>Tapiainen</surname><given-names>T.</given-names></name>; <name><surname>Hanni</surname><given-names>a-M.</given-names></name>; <name><surname>Salo</surname><given-names>J.</given-names></name>; <name><surname>Ik&#x000e4;heimo</surname><given-names>I.</given-names></name>; <name><surname>Uhari</surname><given-names>M.</given-names></name>
<article-title>Escherichia coli biofilm formation
and recurrences of urinary tract
infections in children</article-title>. <source>Eur. J. Clin. Microbiol.
Infect. Dis.</source>
<year>2014</year>, <volume>33</volume>, <fpage>111</fpage>&#x02013;<lpage>115</lpage><pub-id pub-id-type="doi">10.1007/s10096-013-1935-4</pub-id>.<pub-id pub-id-type="pmid">23996047</pub-id></mixed-citation></ref><ref id="ref11"><mixed-citation publication-type="journal" id="cit11"><name><surname>Stickler</surname><given-names>D. J.</given-names></name>; <name><surname>Morgan</surname><given-names>S. D.</given-names></name>
<article-title>Modulation of crystalline Proteus mirabilis biofilm
development on urinary catheters</article-title>. <source>J. Med. Microbiol.</source>
<year>2006</year>, <volume>55</volume>, <fpage>489</fpage>&#x02013;<lpage>494</lpage><pub-id pub-id-type="doi">10.1099/jmm.0.46404-0</pub-id>.<pub-id pub-id-type="pmid">16585633</pub-id></mixed-citation></ref><ref id="ref12"><mixed-citation publication-type="journal" id="cit12"><name><surname>Stickler</surname><given-names>D. J.</given-names></name>
<article-title>Bacterial
biofilms in patients with indwelling urinary catheters</article-title>. <source>Nat. Clin. Pract. Urol.</source>
<year>2008</year>, <volume>5</volume>, <fpage>598</fpage>&#x02013;<lpage>608</lpage><pub-id pub-id-type="doi">10.1038/ncpuro1231</pub-id>.<pub-id pub-id-type="pmid">18852707</pub-id></mixed-citation></ref><ref id="ref13"><mixed-citation publication-type="journal" id="cit13"><name><surname>Nicolle</surname><given-names>L. E.</given-names></name>
<article-title>Catheter
associated urinary tract infections</article-title>. <source>Antimicrob.
Resist. Infect. Control</source>
<year>2014</year>, <volume>3</volume>, <fpage>23</fpage><pub-id pub-id-type="doi">10.1186/2047-2994-3-23</pub-id>.<pub-id pub-id-type="pmid">25075308</pub-id></mixed-citation></ref><ref id="ref14"><mixed-citation publication-type="journal" id="cit14"><name><surname>Davenport</surname><given-names>K.</given-names></name>; <name><surname>Keeley</surname><given-names>F. X.</given-names></name>
<article-title>Evidence for the use of silver-alloy-coated urethral
catheters</article-title>. <source>J. Hosp. Infect.</source>
<year>2005</year>, <volume>60</volume>, <fpage>298</fpage>&#x02013;<lpage>303</lpage><pub-id pub-id-type="doi">10.1016/j.jhin.2005.01.026</pub-id>.<pub-id pub-id-type="pmid">15936115</pub-id></mixed-citation></ref><ref id="ref15"><mixed-citation publication-type="journal" id="cit15"><name><surname>Pickard</surname><given-names>R.</given-names></name>; <name><surname>Lam</surname><given-names>T.</given-names></name>; <name><surname>Maclennan</surname><given-names>G.</given-names></name>; <name><surname>Starr</surname><given-names>K.</given-names></name>; <name><surname>Kilonzo</surname><given-names>M.</given-names></name>; <name><surname>McPherson</surname><given-names>G.</given-names></name>; <name><surname>Gillies</surname><given-names>K.</given-names></name>; <name><surname>McDonald</surname><given-names>A.</given-names></name>; <name><surname>Walton</surname><given-names>K.</given-names></name>; <name><surname>Buckley</surname><given-names>B.</given-names></name>; et al. <article-title>Types of urethral catheter for reducing symptomatic urinary tract
infections in hospitalised adults requiring short-term catheterisation:
multicentre randomised controlled trial and economic evaluation of
antimicrobial- and antiseptic-impregnated urethral</article-title>. <source>Health Technol. Assess.</source>
<year>2012</year>, <volume>16</volume>, <fpage>1</fpage>&#x02013;<lpage>197</lpage><pub-id pub-id-type="doi">10.3310/hta16470</pub-id>.</mixed-citation></ref><ref id="ref16"><mixed-citation publication-type="journal" id="cit16"><name><surname>Tenke</surname><given-names>P.</given-names></name>; <name><surname>K&#x000f6;ves</surname><given-names>B.</given-names></name>; <name><surname>Johansen</surname><given-names>T. E. B.</given-names></name>
<article-title>An update on prevention and treatment
of catheter-associated urinary tract infections</article-title>. <source>Curr. Opin. Infect. Dis.</source>
<year>2014</year>, <volume>27</volume>, <fpage>102</fpage>&#x02013;<lpage>107</lpage><pub-id pub-id-type="doi">10.1097/QCO.0000000000000031</pub-id>.<pub-id pub-id-type="pmid">24345923</pub-id></mixed-citation></ref><ref id="ref17"><mixed-citation publication-type="journal" id="cit17"><name><surname>MacMicking</surname><given-names>J.</given-names></name>; <name><surname>Xie</surname><given-names>Q. W.</given-names></name>; <name><surname>Nathan</surname><given-names>C.</given-names></name>
<article-title>Nitric oxide and macrophage
function</article-title>. <source>Annu. Rev. Immunol.</source>
<year>1997</year>, <volume>15</volume>, <fpage>323</fpage>&#x02013;<lpage>350</lpage><pub-id pub-id-type="doi">10.1146/annurev.immunol.15.1.323</pub-id>.<pub-id pub-id-type="pmid">9143691</pub-id></mixed-citation></ref><ref id="ref18"><mixed-citation publication-type="journal" id="cit18"><name><surname>Cai</surname><given-names>W.</given-names></name>; <name><surname>Wu</surname><given-names>J.</given-names></name>; <name><surname>Xi</surname><given-names>C.</given-names></name>; <name><surname>Ashe</surname><given-names>A. J.</given-names></name>; <name><surname>Meyerhoff</surname><given-names>M. E.</given-names></name>
<article-title>Carboxyl-ebselen-based
layer-by-layer films as potential antithrombotic and antimicrobial
coatings</article-title>. <source>Biomaterials</source>
<year>2011</year>, <volume>32</volume>, <fpage>7774</fpage>&#x02013;<lpage>7784</lpage><pub-id pub-id-type="doi">10.1016/j.biomaterials.2011.06.075</pub-id>.<pub-id pub-id-type="pmid">21794909</pub-id></mixed-citation></ref><ref id="ref19"><mixed-citation publication-type="journal" id="cit19"><name><surname>Riccio</surname><given-names>D. A.</given-names></name>; <name><surname>Schoenfisch</surname><given-names>M. H.</given-names></name>
<article-title>Nitric
oxide release: Part I. Macromolecular scaffolds</article-title>. <source>Chem. Soc. Rev.</source>
<year>2012</year>, <volume>41</volume>, <fpage>3731</fpage><pub-id pub-id-type="doi">10.1039/c2cs15272j</pub-id>.<pub-id pub-id-type="pmid">22362355</pub-id></mixed-citation></ref><ref id="ref20"><mixed-citation publication-type="journal" id="cit20"><name><surname>Barraud</surname><given-names>N.</given-names></name>; <name><surname>Schleheck</surname><given-names>D.</given-names></name>; <name><surname>Klebensberger</surname><given-names>J.</given-names></name>; <name><surname>Webb</surname><given-names>J. S.</given-names></name>; <name><surname>Hassett</surname><given-names>D. J.</given-names></name>; <name><surname>Rice</surname><given-names>S. A.</given-names></name>; <name><surname>Kjelleberg</surname><given-names>S.</given-names></name>
<article-title>Nitric oxide signaling in <italic>Pseudomonas aeruginosa</italic> biofilms mediates phosphodiesterase
activity, decreased cyclic Di-GMP levels, and enhanced dispersal</article-title>. <source>J. Bacteriol.</source>
<year>2009</year>, <volume>191</volume>, <fpage>7333</fpage>&#x02013;<lpage>7342</lpage><pub-id pub-id-type="doi">10.1128/JB.00975-09</pub-id>.<pub-id pub-id-type="pmid">19801410</pub-id></mixed-citation></ref><ref id="ref21"><mixed-citation publication-type="journal" id="cit21"><name><surname>Cai</surname><given-names>W.</given-names></name>; <name><surname>Wu</surname><given-names>J.</given-names></name>; <name><surname>Xi</surname><given-names>C.</given-names></name>; <name><surname>Meyerhoff</surname><given-names>M. E.</given-names></name>
<article-title>Diazeniumdiolate-doped poly(lactic-co-glycolic
acid)-based nitric oxide releasing films as antibiofilm coatings</article-title>. <source>Biomaterials</source>
<year>2012</year>, <volume>33</volume>, <fpage>7933</fpage>&#x02013;<lpage>7944</lpage><pub-id pub-id-type="doi">10.1016/j.biomaterials.2012.07.027</pub-id>.<pub-id pub-id-type="pmid">22841918</pub-id></mixed-citation></ref><ref id="ref22"><mixed-citation publication-type="journal" id="cit22"><name><surname>Ren</surname><given-names>H.</given-names></name>; <name><surname>Wu</surname><given-names>J.</given-names></name>; <name><surname>Xi</surname><given-names>C.</given-names></name>; <name><surname>Lehnert</surname><given-names>N.</given-names></name>; <name><surname>Major</surname><given-names>T.</given-names></name>; <name><surname>Bartlett</surname><given-names>R. H.</given-names></name>; <name><surname>Meyerhoff</surname><given-names>M. E.</given-names></name>
<article-title>Electrochemically
modulated nitric oxide (NO) releasing
biomedical devices via copper(II)-Tri(2-pyridylmethyl)amine mediated
reduction of nitrite</article-title>. <source>ACS Appl. Mater. Interfaces</source>
<year>2014</year>, <volume>6</volume>, <fpage>3779</fpage>&#x02013;<lpage>3783</lpage><pub-id pub-id-type="doi">10.1021/am406066a</pub-id>.<pub-id pub-id-type="pmid">24611831</pub-id></mixed-citation></ref><ref id="ref23"><mixed-citation publication-type="journal" id="cit23"><name><surname>H&#x000f6;fler</surname><given-names>L.</given-names></name>; <name><surname>Koley</surname><given-names>D.</given-names></name>; <name><surname>Wu</surname><given-names>J.</given-names></name>; <name><surname>Xi</surname><given-names>C.</given-names></name>; <name><surname>Meyerhoff</surname><given-names>M. E.</given-names></name>
<article-title>Electromodulated
release of nitric oxide through polymer material from reservoir of
inorganic nitrite salt</article-title>. <source>RSC Adv.</source>
<year>2012</year>, <volume>2</volume>, <fpage>6765</fpage>&#x02013;<lpage>6767</lpage><pub-id pub-id-type="doi">10.1039/c2ra20853a</pub-id>.<pub-id pub-id-type="pmid">22888401</pub-id></mixed-citation></ref><ref id="ref24"><mixed-citation publication-type="journal" id="cit24"><name><surname>Barraud</surname><given-names>N.</given-names></name>; <name><surname>Hassett</surname><given-names>D. J.</given-names></name>; <name><surname>Hwang</surname><given-names>S.-H.</given-names></name>; <name><surname>Rice</surname><given-names>S. a</given-names></name>; <name><surname>Kjelleberg</surname><given-names>S.</given-names></name>; <name><surname>Webb</surname><given-names>J. S.</given-names></name>
<article-title>Involvement of nitric
oxide in biofilm dispersal of
Pseudomonas aeruginosa</article-title>. <source>J. Bacteriol.</source>
<year>2006</year>, <volume>188</volume>, <fpage>7344</fpage>&#x02013;<lpage>7353</lpage><pub-id pub-id-type="doi">10.1128/JB.00779-06</pub-id>.<pub-id pub-id-type="pmid">17050922</pub-id></mixed-citation></ref><ref id="ref25"><mixed-citation publication-type="journal" id="cit25"><name><surname>Brisbois</surname><given-names>E. J.</given-names></name>; <name><surname>Handa</surname><given-names>H.</given-names></name>; <name><surname>Major</surname><given-names>T. C.</given-names></name>; <name><surname>Bartlett</surname><given-names>R. H.</given-names></name>; <name><surname>Meyerhoff</surname><given-names>M. E.</given-names></name>
<article-title>Long-term
nitric oxide release and elevated temperature stability with S-nitroso-N-acetylpenicillamine
(SNAP)-doped Elast-eon E2As polymer</article-title>. <source>Biomaterials</source>
<year>2013</year>, <volume>34</volume>, <fpage>6957</fpage>&#x02013;<lpage>6966</lpage><pub-id pub-id-type="doi">10.1016/j.biomaterials.2013.05.063</pub-id>.<pub-id pub-id-type="pmid">23777908</pub-id></mixed-citation></ref><ref id="ref26"><mixed-citation publication-type="journal" id="cit26"><name><surname>Lee</surname><given-names>J. N.</given-names></name>; <name><surname>Park</surname><given-names>C.</given-names></name>; <name><surname>Whitesides</surname><given-names>G. M.</given-names></name>
<article-title>Solvent
compatibility of poly(dimethylsiloxane)-based
microfluidic devices</article-title>. <source>Anal. Chem.</source>
<year>2003</year>, <volume>75</volume>, <fpage>6544</fpage>&#x02013;<lpage>6554</lpage><pub-id pub-id-type="doi">10.1021/ac0346712</pub-id>.<pub-id pub-id-type="pmid">14640726</pub-id></mixed-citation></ref><ref id="ref27"><mixed-citation publication-type="journal" id="cit27"><name><surname>Elliott</surname><given-names>T. S.</given-names></name>
<article-title>Role of
antimicrobial central venous catheters for the prevention of associated
infections</article-title>. <source>J. Antimicrob. Chemother.</source>
<year>1999</year>, <volume>43</volume>, <fpage>441</fpage>&#x02013;<lpage>446</lpage><pub-id pub-id-type="doi">10.1093/jac/43.4.441</pub-id>.<pub-id pub-id-type="pmid">10350371</pub-id></mixed-citation></ref><ref id="ref28"><mixed-citation publication-type="journal" id="cit28"><name><surname>Sexton</surname><given-names>Daniel J</given-names></name>; <name><surname>Muruganandam</surname><given-names>Arumugam</given-names></name>; <name><surname>McKenney</surname><given-names>Donald J</given-names></name>; <name><surname>Mutus</surname><given-names>B.</given-names></name>
<article-title>Visible light
photochemical release of nitric oxide from S-nitrosoglutathione: potential
photochemotherapeutic applications</article-title>. <source>Photochem.
Photobiol.</source>
<year>1994</year>, <volume>59</volume>, <fpage>463</fpage>&#x02013;<lpage>467</lpage><pub-id pub-id-type="doi">10.1111/j.1751-1097.1994.tb05065.x</pub-id>.<pub-id pub-id-type="pmid">8022889</pub-id></mixed-citation></ref><ref id="ref29"><mixed-citation publication-type="journal" id="cit29"><name><surname>Shishido</surname><given-names>S.</given-names></name>; <name><surname>de Oliveira</surname><given-names>M. G.</given-names></name>
<article-title>Polyethylene glycol matrix reduces the rates of photochemical
and thermal release of nitric oxide from S-nitroso-N-acetylcysteine</article-title>. <source>Photochem. Photobiol.</source>
<year>2000</year>, <volume>71</volume>, <fpage>273</fpage>&#x02013;<lpage>280</lpage><pub-id pub-id-type="doi">10.1562/0031-8655(2000)0710273PGMRTR2.0.CO2</pub-id>.<pub-id pub-id-type="pmid">10732444</pub-id></mixed-citation></ref><ref id="ref30"><mixed-citation publication-type="journal" id="cit30"><name><surname>Frost</surname><given-names>M. C.</given-names></name>; <name><surname>Meyerhoff</surname><given-names>M. E.</given-names></name>
<article-title>Controlled
photoinitiated release of nitric oxide from
polymer films containing S-nitroso-N-acetyl-DL-penicillamine derivatized
fumed silica filler</article-title>. <source>J. Am. Chem. Soc.</source>
<year>2004</year>, <volume>126</volume>, <fpage>1348</fpage>&#x02013;<lpage>1349</lpage><pub-id pub-id-type="doi">10.1021/ja039466i</pub-id>.<pub-id pub-id-type="pmid">14759186</pub-id></mixed-citation></ref><ref id="ref31"><mixed-citation publication-type="journal" id="cit31"><name><surname>Gilmore</surname><given-names>B. F.</given-names></name>; <name><surname>Hamill</surname><given-names>T. M.</given-names></name>; <name><surname>Jones</surname><given-names>D. S.</given-names></name>; <name><surname>Gorman</surname><given-names>S. P.</given-names></name>
<article-title>Validation of the
CDC biofilm reactor as a dynamic model for assessment of encrustation
formation on urological device materials</article-title>. <source>J.
Biomed. Mater. Res., Part B</source>
<year>2010</year>, <volume>93</volume>, <fpage>128</fpage>&#x02013;<lpage>140</lpage><pub-id pub-id-type="doi">10.1002/jbm.b.31567</pub-id>.</mixed-citation></ref><ref id="ref32"><mixed-citation publication-type="journal" id="cit32"><name><surname>Stephens</surname><given-names>A. D.</given-names></name>; <name><surname>Watts</surname><given-names>R. W.</given-names></name>
<article-title>The treatment of cystinuria with N-acetyl-D-penicillamine,
a comparison with the results of D-penicillamine treatment</article-title>. <source>Q. J. Med.</source>
<year>1971</year>, <volume>40</volume>, <fpage>355</fpage>&#x02013;<lpage>370</lpage>.<pub-id pub-id-type="pmid">5564534</pub-id></mixed-citation></ref><ref id="ref33"><mixed-citation publication-type="journal" id="cit33"><name><surname>Carpenter</surname><given-names>A. W.</given-names></name>; <name><surname>Slomberg</surname><given-names>D. L.</given-names></name>; <name><surname>Rao</surname><given-names>K. S.</given-names></name>; <name><surname>Schoenfisch</surname><given-names>M. H.</given-names></name>
<article-title>Influence
of scaffold size on bactericidal activity of nitric oxide-releasing
silica nanoparticles</article-title>. <source>ACS Nano</source>
<year>2011</year>, <volume>5</volume>, <fpage>7235</fpage>&#x02013;<lpage>7244</lpage><pub-id pub-id-type="doi">10.1021/nn202054f</pub-id>.<pub-id pub-id-type="pmid">21842899</pub-id></mixed-citation></ref><ref id="ref34"><mixed-citation publication-type="journal" id="cit34"><name><surname>Lu</surname><given-names>Y.</given-names></name>; <name><surname>Slomberg</surname><given-names>D. L.</given-names></name>; <name><surname>Sun</surname><given-names>B.</given-names></name>; <name><surname>Schoenfisch</surname><given-names>M. H.</given-names></name>
<article-title>Shape-
and nitric oxide flux-dependent bactericidal activity of nitric oxide-releasing
silica nanorods</article-title>. <source>Small</source>
<year>2013</year>, <volume>9</volume>, <fpage>2189</fpage>&#x02013;<lpage>2198</lpage><pub-id pub-id-type="doi">10.1002/smll.201201798</pub-id>.<pub-id pub-id-type="pmid">23362159</pub-id></mixed-citation></ref><ref id="ref35"><mixed-citation publication-type="journal" id="cit35"><name><surname>Donlan</surname><given-names>R. M.</given-names></name>
<article-title>Biofilm
formation: a clinically relevant microbiological process</article-title>. <source>Clin. Infect. Dis.</source>
<year>2001</year>, <volume>33</volume>, <fpage>1387</fpage>&#x02013;<lpage>1392</lpage><pub-id pub-id-type="doi">10.1086/322972</pub-id>.<pub-id pub-id-type="pmid">11565080</pub-id></mixed-citation></ref><ref id="ref36"><mixed-citation publication-type="journal" id="cit36"><name><surname>Ziebuhr</surname><given-names>W.</given-names></name>; <name><surname>Hennig</surname><given-names>S.</given-names></name>; <name><surname>Eckart</surname><given-names>M.</given-names></name>; <name><surname>Kr&#x000e4;nzler</surname><given-names>H.</given-names></name>; <name><surname>Batzilla</surname><given-names>C.</given-names></name>; <name><surname>Kozitskaya</surname><given-names>S.</given-names></name>
<article-title>Nosocomial infections by Staphylococcus
epidermidis: how a commensal bacterium turns into a pathogen</article-title>. <source>Int. J. Antimicrob. Agents</source>
<year>2006</year>, <volume>28</volume><issue>Suppl 1</issue><fpage>S14</fpage>&#x02013;<lpage>S20</lpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2006.05.012</pub-id>.<pub-id pub-id-type="pmid">16829054</pub-id></mixed-citation></ref><ref id="ref37"><mixed-citation publication-type="journal" id="cit37"><name><surname>Fey</surname><given-names>P. D.</given-names></name>; <name><surname>Olson</surname><given-names>M. E.</given-names></name>
<article-title>Current concepts
in biofilm formation of Staphylococcus
epidermidis</article-title>. <source>Future Microbiol.</source>
<year>2011</year>, <volume>5</volume>, <fpage>917</fpage>&#x02013;<lpage>933</lpage><pub-id pub-id-type="doi">10.2217/fmb.10.56</pub-id>.<pub-id pub-id-type="pmid">20521936</pub-id></mixed-citation></ref><ref id="ref38"><mixed-citation publication-type="journal" id="cit38"><name><surname>Hall-stoodley</surname><given-names>L.</given-names></name>; <name><surname>Costerton</surname><given-names>J. W.</given-names></name>; <name><surname>Stoodley</surname><given-names>P.</given-names></name>
<article-title>Bacterial biofilms: from the natural
environment to infectious diseases</article-title>. <source>Nat. Rev.
Microbiol.</source>
<year>2004</year>, <volume>2</volume>, <fpage>95</fpage>&#x02013;<lpage>108</lpage><pub-id pub-id-type="doi">10.1038/nrmicro821</pub-id>.<pub-id pub-id-type="pmid">15040259</pub-id></mixed-citation></ref><ref id="ref39"><mixed-citation publication-type="book" id="cit39"><person-group person-group-type="allauthors"><name><surname>Mack</surname><given-names>D.</given-names></name>; <name><surname>Davies</surname><given-names>A. P.</given-names></name>; <name><surname>Harris</surname><given-names>L. G.</given-names></name>; <name><surname>Jeeves</surname><given-names>R.</given-names></name>; <name><surname>Pascoe</surname><given-names>B.</given-names></name>; <name><surname>Knobloch</surname><given-names>J. K.</given-names></name>; <name><surname>Rohde</surname><given-names>H.</given-names></name>; <name><surname>Wilkinson</surname><given-names>T. S.</given-names></name></person-group><source>Biomaterials Associated
Infection</source>; <person-group person-group-type="editor"><name><surname>Moriarty</surname><given-names>T. F.</given-names></name>, <name><surname>Zaat</surname><given-names>S. A. J.</given-names></name>, <name><surname>Busscher</surname><given-names>H. J.</given-names></name></person-group>, Eds.; <publisher-name>Springer </publisher-name>: <publisher-loc>New York</publisher-loc>, <year>2013</year>; pp <fpage>25</fpage>&#x02013;<lpage>57</lpage>.</mixed-citation></ref><ref id="ref40"><mixed-citation publication-type="journal" id="cit40"><name><surname>Cabrera-Contreras</surname><given-names>R.</given-names></name>; <name><surname>Morelos-Ram&#x000ed;rez</surname><given-names>R.</given-names></name>; <name><surname>Galicia-Camacho</surname><given-names>A. N.</given-names></name>; <name><surname>Mel&#x000e9;ndez-Herrada</surname><given-names>E.</given-names></name>
<article-title>Antibiotic resistance and biofilm
production in <italic>Staphylococcus epidermidis</italic> strains,
isolated from a tertiary care hospital in Mexico City</article-title>. <source>ISRN Microbiol.</source>
<year>2013</year>, <volume>2013</volume>, <elocation-id>918921</elocation-id><pub-id pub-id-type="doi">10.1155/2013/918921</pub-id>.<pub-id pub-id-type="pmid">23724338</pub-id></mixed-citation></ref><ref id="ref41"><mixed-citation publication-type="journal" id="cit41"><name><surname>Wojtyczka</surname><given-names>R. D.</given-names></name>; <name><surname>Orlewska</surname><given-names>K.</given-names></name>; <name><surname>K&#x00065;&#x00328;pa</surname><given-names>M.</given-names></name>; <name><surname>Idzik</surname><given-names>D.</given-names></name>; <name><surname>Dziedzic</surname><given-names>A.</given-names></name>; <name><surname>Mularz</surname><given-names>T.</given-names></name>; <name><surname>Krawczyk</surname><given-names>M.</given-names></name>; <name><surname>Miklasi&#x00144;ska</surname><given-names>M.</given-names></name>; <name><surname>W&#x00105;sik</surname><given-names>T. J.</given-names></name>
<article-title>Biofilm formation and antimicrobial susceptibility
of Staphylococcus epidermidis strains from a hospital environment</article-title>. <source>Int. J. Environ. Res. Public Health</source>
<year>2014</year>, <volume>11</volume>, <fpage>4619</fpage>&#x02013;<lpage>4633</lpage><pub-id pub-id-type="doi">10.3390/ijerph110504619</pub-id>.<pub-id pub-id-type="pmid">24776724</pub-id></mixed-citation></ref><ref id="ref42"><mixed-citation publication-type="journal" id="cit42"><name><surname>Hengzhuang</surname><given-names>W.</given-names></name>; <name><surname>Wu</surname><given-names>H.</given-names></name>; <name><surname>Ciofu</surname><given-names>O.</given-names></name>; <name><surname>Song</surname><given-names>Z.</given-names></name>; <name><surname>H&#x000f8;iby</surname><given-names>N.</given-names></name>
<article-title>Pharmacokinetics/pharmacodynamics
of colistin and imipenem on mucoid and nonmucoid Pseudomonas aeruginosa
biofilms</article-title>. <source>Antimicrob. Agents Chemother.</source>
<year>2011</year>, <volume>55</volume>, <fpage>4469</fpage>&#x02013;<lpage>4474</lpage><pub-id pub-id-type="doi">10.1128/AAC.00126-11</pub-id>.<pub-id pub-id-type="pmid">21670181</pub-id></mixed-citation></ref><ref id="ref43"><mixed-citation publication-type="journal" id="cit43"><name><surname>Jefferson</surname><given-names>K. K.</given-names></name>; <name><surname>Goldmann</surname><given-names>D. A.</given-names></name>; <name><surname>Pier</surname><given-names>G. B.</given-names></name>
<article-title>Use of
confocal microscopy to analyze
the rate of vancomycin penetration through Staphylococcus aureus biofilms</article-title>. <source>Antimicrob. Agents Chemother.</source>
<year>2005</year>, <volume>49</volume>, <fpage>2467</fpage>&#x02013;<lpage>2473</lpage><pub-id pub-id-type="doi">10.1128/AAC.49.6.2467-2473.2005</pub-id>.<pub-id pub-id-type="pmid">15917548</pub-id></mixed-citation></ref><ref id="ref44"><mixed-citation publication-type="journal" id="cit44"><name><surname>Zheng</surname><given-names>Z.</given-names></name>; <name><surname>Stewart</surname><given-names>P. S.</given-names></name>
<article-title>Penetration of Rifampin
through Staphylococcus epidermidis
Biofilms</article-title>. <source>Antimicrob. Agents Chemother.</source>
<year>2002</year>, <volume>46</volume>, <fpage>900</fpage>&#x02013;<lpage>903</lpage><pub-id pub-id-type="doi">10.1128/AAC.46.3.900-903.2002</pub-id>.<pub-id pub-id-type="pmid">11850284</pub-id></mixed-citation></ref><ref id="ref45"><mixed-citation publication-type="journal" id="cit45"><name><surname>Brown</surname><given-names>Michael R. W.</given-names></name>; <name><surname>Allison</surname></name>; <name><surname>David</surname><given-names>G.</given-names></name>; <name><surname>Gilbert</surname><given-names>P.</given-names></name>
<article-title>Resistance
of bacteria biofilms to
antibiotics: a growth-rate related effect?</article-title>. <source>J. Antimicrob. Chemother.</source>
<year>1988</year>, <volume>22</volume>, <fpage>777</fpage>&#x02013;<lpage>783</lpage><pub-id pub-id-type="doi">10.1093/jac/22.6.777</pub-id>.<pub-id pub-id-type="pmid">3072331</pub-id></mixed-citation></ref><ref id="ref46"><mixed-citation publication-type="journal" id="cit46"><name><surname>Walters</surname><given-names>M. C.</given-names></name>; <name><surname>Roe</surname><given-names>F.</given-names></name>; <name><surname>Bugnicourt</surname><given-names>A.</given-names></name>; <name><surname>Franklin</surname><given-names>M. J.</given-names></name>; <name><surname>Stewart</surname><given-names>P. S.</given-names></name>
<article-title>Contributions of
antibiotic penetration, oxygen limitation, and low metabolic activity
to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and
tobramycin</article-title>. <source>Antimicrob. Agents Chemother.</source>
<year>2003</year>, <volume>47</volume>, <fpage>317</fpage>&#x02013;<lpage>323</lpage><pub-id pub-id-type="doi">10.1128/AAC.47.1.317-323.2003</pub-id>.<pub-id pub-id-type="pmid">12499208</pub-id></mixed-citation></ref><ref id="ref47"><mixed-citation publication-type="journal" id="cit47"><name><surname>Jacobsen</surname><given-names>S. M.</given-names></name>; <name><surname>Stickler</surname><given-names>D. J.</given-names></name>; <name><surname>Mobley</surname><given-names>H. L. T.</given-names></name>; <name><surname>Shirtliff</surname><given-names>M. E.</given-names></name>
<article-title>Complicated
catheter-associated urinary tract infections due to Escherichia coli
and Proteus mirabilis</article-title>. <source>Clin. Microbiol. Rev.</source>
<year>2008</year>, <volume>21</volume>, <fpage>26</fpage>&#x02013;<lpage>59</lpage><pub-id pub-id-type="doi">10.1128/CMR.00019-07</pub-id>.<pub-id pub-id-type="pmid">18202436</pub-id></mixed-citation></ref><ref id="ref48"><mixed-citation publication-type="journal" id="cit48"><name><surname>Jones</surname><given-names>B. V.</given-names></name>; <name><surname>Mahenthiralingam</surname><given-names>E.</given-names></name>; <name><surname>Sabbuba</surname><given-names>N. a</given-names></name>; <name><surname>Stickler</surname><given-names>D. J.</given-names></name>
<article-title>Role of swarming
in the formation of crystalline Proteus mirabilis biofilms on urinary
catheters</article-title>. <source>J. Med. Microbiol.</source>
<year>2005</year>, <volume>54</volume>, <fpage>807</fpage>&#x02013;<lpage>813</lpage><pub-id pub-id-type="doi">10.1099/jmm.0.46123-0</pub-id>.<pub-id pub-id-type="pmid">16091430</pub-id></mixed-citation></ref><ref id="ref49"><mixed-citation publication-type="journal" id="cit49"><name><surname>Broomfield</surname><given-names>R. J.</given-names></name>; <name><surname>Morgan</surname><given-names>S. D.</given-names></name>; <name><surname>Khan</surname><given-names>A.</given-names></name>; <name><surname>Stickler</surname><given-names>D. J.</given-names></name>
<article-title>Crystalline bacterial
biofilm formation on urinary catheters by urease-producing urinary
tract pathogens: a simple method of control</article-title>. <source>J. Med. Microbiol.</source>
<year>2009</year>, <volume>58</volume>, <fpage>1367</fpage>&#x02013;<lpage>1375</lpage><pub-id pub-id-type="doi">10.1099/jmm.0.012419-0</pub-id>.<pub-id pub-id-type="pmid">19556373</pub-id></mixed-citation></ref><ref id="ref50"><mixed-citation publication-type="journal" id="cit50"><name><surname>Zunino</surname><given-names>P.</given-names></name>; <name><surname>Sosa</surname><given-names>V.</given-names></name>; <name><surname>Schlapp</surname><given-names>G.</given-names></name>; <name><surname>Allen</surname><given-names>A. G.</given-names></name>; <name><surname>Preston</surname><given-names>A.</given-names></name>; <name><surname>Maskell</surname><given-names>D. J.</given-names></name>
<article-title>Mannose-resistant Proteus-like and P. mirabilis fimbriae
have specific and additive roles in P. mirabilis urinary tract infections</article-title>. <source>FEMS Immunol. Med. Microbiol.</source>
<year>2007</year>, <volume>51</volume>, <fpage>125</fpage>&#x02013;<lpage>133</lpage><pub-id pub-id-type="doi">10.1111/j.1574-695X.2007.00285.x</pub-id>.<pub-id pub-id-type="pmid">17854474</pub-id></mixed-citation></ref><ref id="ref51"><mixed-citation publication-type="journal" id="cit51"><name><surname>Rocha</surname><given-names>S. P. D.</given-names></name>; <name><surname>Pelayo</surname><given-names>J. S.</given-names></name>; <name><surname>Elias</surname><given-names>W. P.</given-names></name>
<article-title>Fimbriae
of uropathogenic Proteus
mirabilis</article-title>. <source>FEMS Immunol. Med. Microbiol.</source>
<year>2007</year>, <volume>51</volume>, <fpage>1</fpage>&#x02013;<lpage>7</lpage><pub-id pub-id-type="doi">10.1111/j.1574-695X.2007.00284.x</pub-id>.<pub-id pub-id-type="pmid">17640292</pub-id></mixed-citation></ref><ref id="ref52"><mixed-citation publication-type="journal" id="cit52"><name><surname>Deupree</surname><given-names>S. M.</given-names></name>; <name><surname>Privett</surname><given-names>B. J.</given-names></name>; <name><surname>Backlund</surname><given-names>C. J.</given-names></name>; <name><surname>Rao</surname><given-names>K. S.</given-names></name>; <name><surname>Johnson</surname><given-names>B.</given-names></name>; <name><surname>Coneski</surname><given-names>P. N.</given-names></name>; <name><surname>Schoenfisch</surname><given-names>M. H.</given-names></name>
<article-title>Synergy
of nitric oxide and silver
sulfadiazine against gram-negative, gram-positive, and antibiotic-resistant
pathogens</article-title>. <source>Mol. Pharm.</source>
<year>2011</year>, <volume>7</volume>, <fpage>2289</fpage>&#x02013;<lpage>2296</lpage><pub-id pub-id-type="doi">10.1021/mp100248e.Synergy</pub-id>.<pub-id pub-id-type="pmid">20939612</pub-id></mixed-citation></ref><ref id="ref53"><mixed-citation publication-type="journal" id="cit53"><name><surname>Hachem</surname><given-names>R.</given-names></name>; <name><surname>Reitzel</surname><given-names>R.</given-names></name>; <name><surname>Borne</surname><given-names>A.</given-names></name>; <name><surname>Jiang</surname><given-names>Y.</given-names></name>; <name><surname>Tinkey</surname><given-names>P.</given-names></name>; <name><surname>Uthamanthil</surname><given-names>R.</given-names></name>; <name><surname>Chandra</surname><given-names>J.</given-names></name>; <name><surname>Ghannoum</surname><given-names>M.</given-names></name>; <name><surname>Raad</surname><given-names>I.</given-names></name>
<article-title>Novel antiseptic
urinary catheters for prevention of urinary tract infections: correlation
of in vivo and in vitro test results</article-title>. <source>Antimicrob.
Agents Chemother.</source>
<year>2009</year>, <volume>53</volume>, <fpage>5145</fpage>&#x02013;<lpage>5149</lpage><pub-id pub-id-type="doi">10.1128/AAC.00718-09</pub-id>.<pub-id pub-id-type="pmid">19805562</pub-id></mixed-citation></ref><ref id="ref54"><mixed-citation publication-type="journal" id="cit54"><name><surname>Darouiche</surname><given-names>R. O.</given-names></name>; <name><surname>Smith</surname><given-names>J. A.</given-names></name>; <name><surname>Hanna</surname><given-names>H.</given-names></name>; <name><surname>Dhabuwala</surname><given-names>C. B.</given-names></name>; <name><surname>Steiner</surname><given-names>M. S.</given-names></name>; <name><surname>Babaian</surname><given-names>R. J.</given-names></name>; <name><surname>Boone</surname><given-names>T. B.</given-names></name>; <name><surname>Scardino</surname><given-names>P. T.</given-names></name>; <name><surname>Thornby</surname><given-names>J. I.</given-names></name>; <name><surname>Raad</surname><given-names>I. I.</given-names></name>
<article-title>Efficacy of antimicrobial-impregnated
bladder catheters in reducing catheter-associated bacteriuria: a prospective,
randomized, multicenter clinical trial</article-title>. <source>Urology</source>
<year>1999</year>, <volume>54</volume>, <fpage>976</fpage>&#x02013;<lpage>981</lpage><pub-id pub-id-type="doi">10.1016/S0090-4295(99)00288-5</pub-id>.<pub-id pub-id-type="pmid">10604693</pub-id></mixed-citation></ref><ref id="ref55"><mixed-citation publication-type="journal" id="cit55"><name><surname>Anderson</surname><given-names>G. G.</given-names></name>; <name><surname>O&#x02019;Toole</surname><given-names>G. A.</given-names></name>
<article-title>Innate
and induced resistance mechanisms of bacterial
biofilms</article-title>. <source>Curr. Top. Microbiol. Immunol.</source>
<year>2008</year>, <volume>322</volume>, <fpage>85</fpage>&#x02013;<lpage>105</lpage>.<pub-id pub-id-type="pmid">18453273</pub-id></mixed-citation></ref><ref id="ref56"><mixed-citation publication-type="journal" id="cit56"><name><surname>Aiassa</surname><given-names>V.</given-names></name>; <name><surname>Barnes</surname><given-names>A. I.</given-names></name>; <name><surname>Albesa</surname><given-names>I.</given-names></name>
<article-title>Resistance
to ciprofloxacin by enhancement
of antioxidant defenses in biofilm and planktonic Proteus mirabilis</article-title>. <source>Biochem. Biophys. Res. Commun.</source>
<year>2010</year>, <volume>393</volume>, <fpage>84</fpage>&#x02013;<lpage>88</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2010.01.083</pub-id>.<pub-id pub-id-type="pmid">20097163</pub-id></mixed-citation></ref><ref id="ref57"><mixed-citation publication-type="journal" id="cit57"><name><surname>Hoffman</surname><given-names>L. R.</given-names></name>; <name><surname>D&#x02019;Argenio</surname><given-names>D. A.</given-names></name>; <name><surname>MacCoss</surname><given-names>M. J.</given-names></name>; <name><surname>Zhang</surname><given-names>Z.</given-names></name>; <name><surname>Jones</surname><given-names>R. A.</given-names></name>; <name><surname>Miller</surname><given-names>S. I.</given-names></name>
<article-title>Aminoglycoside
antibiotics induce bacterial biofilm
formation</article-title>. <source>Nature</source>
<year>2005</year>, <volume>436</volume>, <fpage>1171</fpage>&#x02013;<lpage>1175</lpage><pub-id pub-id-type="doi">10.1038/nature03912</pub-id>.<pub-id pub-id-type="pmid">16121184</pub-id></mixed-citation></ref></ref-list></back></article>